Design Therapeutics, Inc. (DSGN) - Quarterly Income Statement

Home
DSGN
Financials

4.39 (USD) • At close April 29, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	0	0	0	0	0.838	0	0	0	0	0	0	0	0	0	0	0	0.033	0.02	0.031	0.142
Cost of Revenue Numbers are in millions	0	0	0.151	0.143	0.138	0.137	0.143	0.139	0.135	0.122	0.113	0.096	0.082	0.031	0.012	0.004	2.708	1.914	1.061	0.377
Gross Profit Numbers are in millions	0	0	-0.151	-0.143	0.7	-0.137	-0.143	-0.139	-0.135	-0.122	-0.113	-0.096	-0.082	-0.031	-0.012	-0.004	-2.675	-1.894	-1.03	-0.235
Gross Profit Ratio Numbers are in millions	0	0	0	0	0.835	0	0	0	0	0	0	0	0	0	0	0	-81.061	-94.7	-33.226	-1.655
Reseach & Development Expenses Numbers are in millions	12.157	11.876	10.365	9.658	10.874	13.257	17.064	15.73	14.255	14.304	11.295	8.759	7.337	8.539	5.027	3.875	2.708	1.914	1.061	0.377
General & Administrative Expenses Numbers are in millions	4.537	4.37	4.527	4.599	4.109	5.565	5.532	5.921	5.137	4.888	4.344	4.611	3.79	2.798	2.66	1.805	1.186	0.489	0.433	0.388
Selling & Marketing Expenses Numbers are in millions	0	0	0.076	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	4.537	4.37	4.527	4.599	4.109	5.565	5.532	5.921	5.137	4.888	4.344	4.611	3.79	2.798	2.66	1.805	1.186	0.489	0.433	0.388
Other Expenses Numbers are in millions	0	0	3.25	3.295	3.279	3.033	2.659	2.357	2.052	1.488	0.64	0.105	0.062	0.019	0.051	0.166	0.006	0.063	0.021	-0.04
Operating Expenses Numbers are in millions	16.694	16.246	14.892	14.257	14.983	18.822	22.596	21.651	19.392	19.192	15.639	13.37	11.127	11.337	7.687	5.68	3.861	2.383	1.463	0.623
Operating Income Numbers are in millions	-16.694	-16.246	-15.043	-14.4	-15.121	-18.822	-22.596	-21.651	-19.392	-19.192	-15.639	-13.37	-11.127	-11.337	-7.687	-5.68	-3.861	-2.383	-1.463	-0.623
Operating Income Ratio Numbers are in millions	0	0	0	0	-18.044	0	0	0	0	0	0	0	0	0	0	0	-117	-119.15	-47.194	-4.387
Total Other Income Expenses Net Numbers are in millions	3.043	3.207	3.25	3.295	3.279	3.033	2.659	2.357	2.052	1.488	0.64	0.105	0.062	0.019	0.051	0.166	0.006	0.063	0.021	-0.04
Income Before Tax Numbers are in millions	-13.651	-13.039	-11.793	-11.105	-11.842	-15.789	-19.937	-19.294	-17.34	-17.704	-14.999	-13.265	-11.065	-11.318	-7.636	-5.514	-3.855	-2.32	-1.442	-0.663
Income Before Tax Ratio Numbers are in millions	0	0	0	0	-14.131	0	0	0	0	0	0	0	0	0	0	0	-116.818	-116	-46.516	-4.669
Income Tax Expense Numbers are in millions	0	0	0	0.1	2.494	-0.137	0.011	-2.357	-2.176	-1.488	-0.64	-0.105	-0.062	0	0	0	0	0	-1.463	-0.623
Net Income Numbers are in millions	-13.651	-13.039	-11.793	-11.105	-11.842	-15.789	-19.937	-16.937	-15.164	-16.216	-14.359	-13.16	-11.065	-11.318	-7.636	-5.514	-3.855	-2.32	-1.442	-0.663
Net Income Ratio Numbers are in millions	0	0	0	0	-14.131	0	0	0	0	0	0	0	0	0	0	0	-116.818	-116	-46.516	-4.669
EPS Numbers are in millions	-0.24	-0.23	-0.21	-0.2	-0.21	-0.28	-0.36	-0.3	-0.27	-0.29	-0.26	-0.24	-0.2	-0.21	-0.14	-0.31	-0.14	-0.085	-0.053	-0.024
EPS Diluted Numbers are in millions	-0.24	-0.23	-0.21	-0.2	-0.21	-0.28	-0.36	-0.3	-0.27	-0.29	-0.26	-0.24	-0.2	-0.21	-0.14	-0.31	-0.14	-0.085	-0.053	-0.024
EBITDA Numbers are in millions	-16.545	-16.093	-14.892	-14.257	-14.983	-18.685	-22.463	-21.522	-19.268	-19.084	-15.547	-13.288	-11.045	-11.306	-7.675	-5.676	-3.857	-2.383	0.021	-0.04
EBITDA Ratio Numbers are in millions	0	0	0	0	-17.879	0	0	0	0	0	0	0	0	0	0	0	-116.879	-119.133	0.677	-0.282

Design Therapeutics, Inc.

NASDAQ:DSGN Add to watchlist

NASDAQ:DSGN